An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease
Background: Hepatitis C virus infection remains common in patients with chronic kidney disease, including those on maintenance dialysis. The relationship between hepatitis C virus infection and chronic kidney disease is bi-directional; in fact, HCV is both a cause and consequence of chronic kidney d...
Enregistré dans:
Auteurs principaux: | Fabrizio Fabrizi, Roberta Cerutti, Piergiorgio Messa |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c2faed92fb824559a1e6e699aa65e3b6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant
par: Fabrizio Fabrizi, et autres
Publié: (2021) -
Hepatitis aguda por virus C: reporte de siete casos en centro de referencia en Chile
par: Urzúa,Álvaro, et autres
Publié: (2020) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
par: Vicente Soriano, et autres
Publié: (2022) -
Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
par: María E. Cárdaba-García, et autres
Publié: (2021) -
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
par: Cesare Mazzaro, et autres
Publié: (2021)